Extracorporeal carbon dioxide removal for patients with acute respiratory failure: a systematic review and meta-analysis.

ABSTRACT:

Background

Acute respiratory failure (ARF) is a common clinical critical syndrome with substantial mortality. Extracorporeal carbon dioxide removal (ECCO₂R) has been proposed for the treatment of ARF. However, whether ECCO₂R could provide a survival advantage for patients with ARF is still controversial.

Methods

Electronic databases (PubMed, Embase, Web of Science, and the Cochrane database) were searched from inception to 30 April 2022. Randomized controlled trials (RCTs) and observational studies that examined the following outcomes were included: mortality, length of hospital and ICU stay, intubation and tracheotomy rate, mechanical ventilation days, ventilator-free days (VFDs), respiratory parameters, and reported adverse events.

Results

Four

SUBMITTER: Zhou Z 

PROVIDER: S-EPMC9980035 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature